Surgical management after neoadjuvant imatinib therapy in gastrointestinal stromal tumours (GISTs) with respect to imatinib resistance caused by secondary KIT mutations.
about
Using endoscopy to minimize the extent of resection in the management of giant GISTs of the stomach.Downsizing treatment with tyrosine kinase inhibitors in patients with advanced gastrointestinal stromal tumors improved resectability.Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors.Resistance to chemotherapy and molecularly targeted therapies: rationale for combination therapy in malignant melanomaPrimary localized rectal/pararectal gastrointestinal stromal tumors: results of surgical and multimodal therapy from the French Sarcoma group.Preoperative imatinib treatment in patients with advanced gastrointestinal stromal tumors: patient experiences and systematic review of 563 patients.Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era.A rare case of primary mesenteric gastrointestinal stromal tumor with metastasis to the cervix uteri.Prolonged Therapy with Imatinib Mesylate before Surgery for Advanced Gastrointestinal Stromal Tumor Results of a Phase II TrialImatinib as preoperative therapy in Chinese patients with recurrent or metastatic GISTs.Surgical treatment of gastric gastrointestinal stromal tumorDuodenal GIST: a single center experiencePhase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665.Neoadjuvant imatinib: longer the better, need to modify risk stratification for adjuvant imatinib.Imatinib mesylate neoadjuvant treatment for rectal malignant gastrointestinal stromal tumor.Reintroduction of imatinib in GISTImatinib treatment for gastrointestinal stromal tumour (GIST).Optimizing imatinib mesylate treatment in gastrointestinal stromal tumorsPreoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST).Mechanisms of resistance to imatinib and sunitinib in gastrointestinal stromal tumor.Adjuvant therapy of gastrointestinal stromal tumors (GIST).The Role of Surgery in Metastatic Gastrointestinal Stromal Tumors.To condition or not to condition-That is the question: The evolution of nonmyeloablative conditions for transplantation.Selective RNAi-mediated inhibition of mutated c-kit.Long-surviving patients with recurrent GIST after receiving cytoreductive surgery with imatinib therapy.Massive intra-abdominal imatinib-resistant gastrointestinal stromal tumor in a 21-year-old male.Sphincter sparing resection of a large obstructive distal rectal gastrointestinal stromal tumour after neoadjuvant therapy with imatinib (Glivec).Analysis of long-term survival after hepatectomy for isolated liver metastasis of gastrointestinal stromal tumour.Liver surgery in the multidisciplinary management of gastrointestinal stromal tumour.Liver surgery in the multidisciplinary management of gastrointestinal stromal tumour.Laparoscopic sphincter-preserving surgery (intersphincteric resection) after neoadjuvant imatinib treatment for gastrointestinal stromal tumor (GIST) of the rectum.Ultrasound-Guided Intraoperative Radiofrequency Ablation and Surgical Resection for Liver Metastasis from Malignant Gastrointestinal Stromal Tumors.Giant gastrointestinal stromal tumor of the vermiform appendix: A case report.MiR-320a downregulation is associated with imatinib resistance in gastrointestinal stromal tumors.Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience.Management of hemorrhage in gastrointestinal stromal tumors: a review.The combination of surgery and imatinib in GIST: a reality for localized tumors at high risk, an open issue for metastatic ones.Surgical treatment of gastrointestinal stromal tumour of the rectum in the era of imatinib.
P2860
Q33716121-C499B223-8FF4-45C6-9684-532F5E78CD65Q34050275-9FA38233-4C28-4C2D-8604-2A4C8D0201C7Q34202396-005E0DA1-0680-428A-9564-345D96937601Q34497045-0B1A7FFA-5F96-44C0-A890-3573BB400660Q35111851-CDAE1626-933D-48DE-B977-C6FCDA7B3D2EQ35676187-27F9CBAA-C759-4575-97A8-869DC4C74607Q35791389-0CB2BF9D-9D39-4B97-A404-0C2B153E2BA1Q36417321-A246AB27-5FA6-4FF8-BA6D-6A71DF869AD6Q36499861-3ED5119A-BF27-415C-A375-D7E1D29B65DBQ36563238-D2009AD8-E531-448D-BE5F-004907E89C36Q36770203-F8DC830F-F46D-452D-A714-58D8CB6BBFFCQ36803986-56AE8559-3CFD-4A73-AAE8-1C44DAA28239Q37023177-96320696-7D83-44CB-9E90-486199717309Q37131713-3F918101-1876-4EAF-9A8E-AD52E1A56D63Q37161655-0C7FCDCB-9E5A-4DDB-B452-419FC90A9C56Q37301364-45D6BF89-3D65-404E-A02C-2C753F565165Q37334993-8330E515-9656-4158-BC39-F6269EDBD134Q37405941-6E0E8C64-3B8D-47E1-B4D7-413F5876AC26Q37747750-5F25CEB5-2D0B-4F62-974C-2FF67E37C1A1Q37823438-6CA2939F-C8AA-44C3-9E01-9F282E0AB99EQ38022443-18CEE3A6-A393-49EB-948B-9B19AC172F51Q38714790-A178045F-3B3A-407F-9EEA-63B73830BEF9Q38829078-9EBA6E70-6647-4F9E-A51E-BC9145FCF5F2Q41836202-0ED4004C-B052-4F24-A0EC-161FD574DFD9Q42134185-13DDC00C-6DEA-4482-8ADA-042CFEB30F39Q42560774-669C77F1-364B-498E-AB53-1EB120C0A2A9Q43100127-0F8C2429-A8FA-4B60-B4D6-CC8343A60A22Q43730826-285EF97B-CCC4-4631-A201-579DCFE1C39AQ43903971-DB500A7D-CC33-4EBD-BFFA-8213A81BB320Q44700932-B1811D77-2CF7-4280-8C64-6F1DC2EC0976Q46114032-C619CA73-3425-4F0C-A151-A6AF28748959Q49237178-D3B152FE-41B3-44E4-AA4E-D6294A662C2CQ50144404-F792838E-529D-497F-857B-26BF1AED953AQ50469164-B170F71D-7619-48BC-949A-724D17211339Q50913835-B1C7E95A-A4A1-42F8-BF3C-7B2BE5B65B2AQ52562706-28A98531-20BD-4081-8CF9-A4CF62F90030Q54539960-E0CBD779-6CB6-4D5D-9ECC-79B21B9B50DDQ55059101-9CB2A7EC-8E74-4691-8411-13A001D98685
P2860
Surgical management after neoadjuvant imatinib therapy in gastrointestinal stromal tumours (GISTs) with respect to imatinib resistance caused by secondary KIT mutations.
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Surgical management after neoa ...... ed by secondary KIT mutations.
@ast
Surgical management after neoa ...... ed by secondary KIT mutations.
@en
type
label
Surgical management after neoa ...... ed by secondary KIT mutations.
@ast
Surgical management after neoa ...... ed by secondary KIT mutations.
@en
prefLabel
Surgical management after neoa ...... ed by secondary KIT mutations.
@ast
Surgical management after neoa ...... ed by secondary KIT mutations.
@en
P2093
P1476
Surgical management after neoa ...... ed by secondary KIT mutations.
@en
P2093
Bastian Gunawan
Florian Haller
Hans-Jürgen Schulten
Jens Kuhlgatz
László Füzesi
Nicole Happel
Sven Detken
P2888
P304
P356
10.1245/S10434-006-9228-0
P577
2006-12-02T00:00:00Z
P6179
1024470042